The identification of functional receptors /ion channels in bladder urothelial (UT) cells and the involvement, in turn, of these in the release of chemical mediators (acetylcholine, ATP, substance P) suggest that UT cells exhibit specialised sensory and signalling properties. In addition, stimulation of various 'sensor molecules'(i.e. muscarinic, purinergic, neurokinin and TRP channels, stretch receptors) can all elicit release of a number of neurotransmitters from UT cells. However, there is virtually no information as to the mechanism(s) for this release. The goals of this proposal are to utilize fluorescent FM dyes to track the movement of stimulus evoked dye -filled vesicles in order to provide information as to the trafficking events underlying transmitter release by UT cells. While FM dyes have been utilized in neurons as an 'activity marker', their use in UT cells to correlate vesicle traffic and release mechanisms, is novel and should provide new information as to how UT cells respond to chemical and mechanical stimuli.
Specific Aim I will characterize chemical versus mechanical evoked vesicle trafficking in urothelial cells.
Specific Aim II will evaluate the intracellular mechanisms underlying urothelial cell vesicular trafficking responses to chemical and mechanical stimuli, the cytosolic location of vesicular pools and the identity (to a limited degree) of the vesicular cargo.
Specific Aim III will evaluate the vesicle trafficking profile in urothelial following pathology. We and others have shown that injury or inflammation results in augmented release of chemical- or stretch-evoked neurotransmitters from the urothelium. Alterations in urothelial-derived mediators could alter the activity of bladder nerves in close proximity to the UT and impact bladder function. Thus, in this aim, we will examine how inflammation alters stimulus-evoked vesicular traffic. Results from these studies will provide information as to how urothelial cells receive and integrate multiple stimuli.
Understanding the mechanisms of the vesicle trafficking may provide important insight for the identification of novel treatments (such as targeting urothelial release mechanisms) for the future clinical management of bladder dysfunctions.
|Hanna-Mitchell, Ann T; Wolf-Johnston, Amanda S; Barrick, Stacey R et al. (2015) Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn 34:79-84|
|Kanai, Anthony; Fry, Christopher; Hanna-Mitchell, Ann et al. (2014) Do we understand any more about bladder interstitial cells?-ICI-RS 2013. Neurourol Urodyn 33:573-6|
|Hanna-Mitchell, Ann T; Wolf-Johnston, Amanda; Roppolo, James R et al. (2014) Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cells. J Endocrinol 222:113-21|
|Hanna-Mitchell, Ann T; Kashyap, Mandavi; Chan, Wilson Ventura et al. (2014) Pathophysiology of idiopathic overactive bladder and the success of treatment: a systematic review from ICI-RS 2013. Neurourol Urodyn 33:611-7|
|Birder, Lori A; Andersson, Karl-Erik; Kanai, Anthony J et al. (2014) Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013. Neurourol Urodyn 33:597-601|
|Hanna-Mitchell, Ann T; Ruiz, Giovanni W; Daneshgari, Firouz et al. (2013) Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol 304:R84-93|
|Wolf-Johnston, Amanda S; Hanna-Mitchell, Ann T; Buffington, Charles A et al. (2012) Alterations in the non-neuronal acetylcholine synthesis and release machinery in esophageal epithelium. Life Sci 91:1065-9|
|Ikeda, Youko; Zabbarova, Irina V; Birder, Lori A et al. (2012) Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder. Eur Urol 62:1157-64|
|Kanai, Anthony; Zabbarova, Irina; Ikeda, Youko et al. (2011) Sophisticated models and methods for studying neurogenic bladder dysfunction. Neurourol Urodyn 30:658-67|
|Birder, Lori A; Hanna-Mitchell, Ann T; Mayer, Emeran et al. (2011) Cystitis, co-morbid disorders and associated epithelial dysfunction. Neurourol Urodyn 30:668-72|
Showing the most recent 10 out of 11 publications